OXIS

This brand name is authorized in Australia, Austria, Cyprus, Estonia, Finland, Germany, Ireland, Italy, Japan, Malta, Netherlands, New Zealand, Poland, South Africa, Spain, UK.

Active ingredients

The drug OXIS contains one active pharmaceutical ingredient (API):

1	Formoterol fumarate dihydrate UNII W34SHF8J2K - FORMOTEROL FUMARATE
	Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.
	Read more about Eformoterol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OXIS Inhalation powder	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03AC13	Formoterol	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8239P, 8240Q
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02143608, 02147003, 02159696, 02159710, 08510249, 08510261, 08859041, 08859058, 10090820, 10090837, 10249870, 10542305, 10730099, 10759068, 10828131
EE	Ravimiamet	1034064, 1034075
ES	Centro de información online de medicamentos de la AEMPS	61666, 61667
FI	Lääkealan turvallisuus- ja kehittämiskeskus	115904, 396080, 458677, 582556
GB	Medicines & Healthcare Products Regulatory Agency	139439, 139441, 147057, 147065, 162193, 162195, 32439, 32453, 374439, 375752
IE	Health Products Regulatory Authority	38946, 38989
IT	Agenzia del Farmaco	033312024
JP	医薬品医療機器総合機構	2259711G1024, 2259711G2020
MT	Medicines Authority	MA046/02201, MA046/02202
NL	Z-Index G-Standaard	14070235, 14070243
NL	Z-Index G-Standaard, PRK	66478, 66486
NZ	Medicines and Medical Devices Safety Authority	7866
PL	Rejestru Produktów Leczniczych	100089600, 100213388
ZA	Health Products Regulatory Authority	32/10.2.1/0168